The INL Podcast INL Asia

In this two-part episode, Dr Michael Osiecki PhD and Managing Director of Bio Concepts joins INL’s Founder Graeme Bradshaw for an in-depth visual discussion about gut health at a cellular level. Dr Michael Osiecki draws insights from the latest relevant research as well as his wealth of experience in Biochemistry and specialism in Cell Biology.
Not only will this episode unveil what you may have always wanted to know about the specifics of the cellular mechanisms being constantly influenced by the intestinal environment, but Graeme and Dr Osiecki discuss the clinical implications of the cellular world of the gut.

In this episode, Gina Patrick, INL’s Director of Sales and Marketing, joins INL’s Founder Graeme Bradshaw to discuss the most researched probiotic formula in the clinical setting, the De Simone Formulation also known as the high strength probiotic brand Vivomixx.
This formula has been central to 80 clinical studies, the topic of over 200 articles and covering approximately 5,000 patients worldwide of many demographics. As research mounts and we keep discovering how pivotal the microbiome is to health, it is exciting to discuss how this high strength probiotic is the leading therapeutic choice for many health concerns, not just limited to digestive issues.
Graeme and Gina talk about what makes this probiotic unique and cover the array of clinical applications and dosage considerations.
 
 

n this episode, Alan Patrick from Asia Medical Solutions joins IMI’s and INL's Founder Graeme Bradshaw to discuss practitioners' frequently asked questions on H.Pylori and related digestive complaints, a topic in which Graeme has a wealth of clinical experience.
Graeme and Alan discuss the discovery and epidemiology of the bacteria and expand on pathological consequences for patients and whether it can be innocuous.
They cover how to measure H.Pylori, what the different methods of diagnostic testing show and what the results would mean for clinical application.
The GIMAP is a quantitative diagnostic test, flagging when low levels of H.Pylori are present which is often missed by other lab tests, they discuss what this means, the H. pylori decision-making process; when to treat or not to treat.
As the conversion develops, they talk about how you can use H.Pylori as a barometer for digestive function, which is not only vital in itself but crucial for solving the route cause of many digestive conditions that patient present with.

IMI and INL's founder, Graeme Bradshaw is joined by Dr Tim Trodd, who specialised in Family Medicine with qualifications from the UK and Hong Kong. Dr Trodd is a well known functional medicine expert in HK and Co-Founder of OT&P, a fully Integrated Functional Medicine Clinic in Hong Kong covering the specialities of Detox, Immunity, Hormones, Women's Health, Cancer, Anti-Aging, Therapies, Gut Health. Heavy Metal Detox.
In this episode, Dr Trodd discusses his Functional Medicine approach to managing ASD patients by addressing key deficiencies, the role of Methylation and how looking at key metabolite and cofactors levels give important clues as to how to uncover the patient's individual needs far beyond standard MTHR gene variant testing.
Together they share experience and explore how modern-day living has multiple triggers for high systemic inflammation levels impacted by oxidative stress, nutrition; particularly affecting gut health and the epigenetic factors in the population which has set the stage for a rise in neuroinflammatory disease cases.

In this episode, Alan Patrick from Asia Medical Solutions joins IMI and INL's Founder Graeme Bradshaw to discuss practitioners' frequently asked questions on best practices for interpretation of GI Map Report.
The GI-MAP (Microbial Assay Plus) is unique in the field of comprehensive stool testing. It relies exclusively on quantitative polymerase chain reaction (qPCR) technology to detect parasites, bacteria, fungi, and more, by targeting the specific DNA of the organisms tested

This discussion covers interpretation and protocols to support optimal treatment planning.

In this episode, Alan Patrick from Asia Medical Solutions joins IMI and INL's Founder Graeme Bradshaw to discuss practitioners' frequently asked questions on best practices for treating patients with Small Intestinal Bacterial Overgrowth (SIBO).

The discussion covers diagnostics, prognosis and post-treatment protocols to support optimal treatment planning.